Abstract
Gitelman sendromu (GS), hipokalemik metabolik alkaloz ile birlikte hipomagnezemi ve hipokalsiüri ile seyreden ve erişkinde
en sık saptanan herediter tübülopatidir. Gitelman sendromu distal kıvrımlı tübülde tiazid duyarlı Na-Cl kotransport
kanalını kodlayan SLC12A3 geninde mutasyon sonucu ortaya çıkar. Genellikle erişkin yaşta tespit edilmesine karşın
çoğu altı yaşından sonra ortaya çıkar. Gitelman sendromunun klinik belirti vererek 6 yaşından önce tanı alması nadirdir.
Biz beş yaşında tetani ile başvuran ve Gitelman Sendromu tanısı koyduğumuz bir hastamızı literatürü gözden geçirerek
sunduk.
Keywords
References
- 1. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Phys 1966;79:221–35.
- 2. Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 2008 30;3:22.
- 3. Devuyst O, Belge H, Konrad M, Jeunemaitre X, Zennaro MC. Renal tubular disorders of electrolyte regulation in children. In: Avner ED, Harmon VE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, (eds). 7th ed. Pediatric Nephrology. Berlin, Heidelberg: Springer-Verlag, 2016:1215-21.
- 4. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazidesensitive Na-Cl cotransporter. Nat Gen 1996;12:24–30.
- 5. Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, et al. Spectrum of mutations in Gitelman Syndrome. J Am Soc Nephrol 2011;22:693–703.
- 6. Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman Syndrome. J Am Soc Nephrol 2015;26:271–9.
- 7. Tammaro F, Bettinelli A, Cattarelli D, Cavazza A, Colombo C, Syrén ML, et al. Early appearance of hypokalemia in Gitelman syndrome. Pediatr Nephrol 2010; 25: 2179-82.
- 8. Nandi M, Pandey G, Sarkar S. Gitelman syndrome in an infant. Indian J Nephrol 2015; 25:316.
- 9. Sinha A, Lněnička P, Basu B, Gulati A, Hari P, Bagga A. Gitelman syndrome: Novel mutation and long-term follow-up. Clin Exp Nephrol 2012;16:306-9.
- 10. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 2001;81:51–84.
- 11. Punzi L, Calò L, Schiavon F, Pianon M, Rosada M, Todesco S. Chondrocalcinosis is a feature of Gitelman’s variant of Bartter’s syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease. Rev Rhum Engl Ed 1998;65:571–4.
- 12. Bourcier T, Blain P, Massin P, Gr€unfeld JP, Gaudric A. Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol 1999;128:767–78.
- 13. Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 2002; 62:580–4.
- 14. Bulucu F, Vural A, Yenicesu M, Caglar K. Association of Gitelman’s syndrome and focal segmental glomerulosclerosis. Nephron 1998;79:244.
- 15. Hanevold C, Mian A, Dalton R. C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol 2006;21:1904– 8.
- 16. Ceri M, Unverdi S, Altay M, Unverdi H, Kurultak I, Yilmaz R, et al. Focal segmental glomerulosclerosis in association with Gitelman syndrome. Int Urol Nephrol 2011;43: 905–7.
- 17. Demoulin N, Aydin S, Cosyns JP, Dahan K, Cornet G, Auberger I, et al. Gitelman syndrome and glomerular proteinuria: A link between loss of sodium-chloride cotransporter and podocyte dysfunction? Nephrol Dial Transplant 2014; 29: iv117–20.
- 18. Larkins N, Wallis M, McGillivray B, Mammen C. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin. Clin Kidney J 2014;7:306-10.
Abstract
References
- 1. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Phys 1966;79:221–35.
- 2. Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 2008 30;3:22.
- 3. Devuyst O, Belge H, Konrad M, Jeunemaitre X, Zennaro MC. Renal tubular disorders of electrolyte regulation in children. In: Avner ED, Harmon VE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, (eds). 7th ed. Pediatric Nephrology. Berlin, Heidelberg: Springer-Verlag, 2016:1215-21.
- 4. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazidesensitive Na-Cl cotransporter. Nat Gen 1996;12:24–30.
- 5. Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, et al. Spectrum of mutations in Gitelman Syndrome. J Am Soc Nephrol 2011;22:693–703.
- 6. Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman Syndrome. J Am Soc Nephrol 2015;26:271–9.
- 7. Tammaro F, Bettinelli A, Cattarelli D, Cavazza A, Colombo C, Syrén ML, et al. Early appearance of hypokalemia in Gitelman syndrome. Pediatr Nephrol 2010; 25: 2179-82.
- 8. Nandi M, Pandey G, Sarkar S. Gitelman syndrome in an infant. Indian J Nephrol 2015; 25:316.
- 9. Sinha A, Lněnička P, Basu B, Gulati A, Hari P, Bagga A. Gitelman syndrome: Novel mutation and long-term follow-up. Clin Exp Nephrol 2012;16:306-9.
- 10. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 2001;81:51–84.
- 11. Punzi L, Calò L, Schiavon F, Pianon M, Rosada M, Todesco S. Chondrocalcinosis is a feature of Gitelman’s variant of Bartter’s syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease. Rev Rhum Engl Ed 1998;65:571–4.
- 12. Bourcier T, Blain P, Massin P, Gr€unfeld JP, Gaudric A. Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol 1999;128:767–78.
- 13. Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 2002; 62:580–4.
- 14. Bulucu F, Vural A, Yenicesu M, Caglar K. Association of Gitelman’s syndrome and focal segmental glomerulosclerosis. Nephron 1998;79:244.
- 15. Hanevold C, Mian A, Dalton R. C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol 2006;21:1904– 8.
- 16. Ceri M, Unverdi S, Altay M, Unverdi H, Kurultak I, Yilmaz R, et al. Focal segmental glomerulosclerosis in association with Gitelman syndrome. Int Urol Nephrol 2011;43: 905–7.
- 17. Demoulin N, Aydin S, Cosyns JP, Dahan K, Cornet G, Auberger I, et al. Gitelman syndrome and glomerular proteinuria: A link between loss of sodium-chloride cotransporter and podocyte dysfunction? Nephrol Dial Transplant 2014; 29: iv117–20.
- 18. Larkins N, Wallis M, McGillivray B, Mammen C. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin. Clin Kidney J 2014;7:306-10.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | Case Report |
| Authors | |
| Publication Date | December 30, 2018 |
| Submission Date | January 14, 2018 |
| Published in Issue | Year 2018 Volume: 12 Issue: 4 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.